Lava Medtech Acquisition (LVAC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LVAC Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Lava Medtech Acquisition manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent1.16
Cash & Short-term Investments1.00
Other Receivables8.18
Prepaid Expense And Other Assets Current0.21
Total Current Assets1.37
Tax Assets, Noncurrent0.32
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent0.00
Deferred Income Tax Assets Net0.00
Total Assets120.67
Liabilities
Accounts Payable, Current AC0.22
Accrued Liabilities, Current6.75
Financial Instruments0.08
Other Liabilities, Current0.00
Taxes Payable0.36
Deferred Liability and Revenue4.03
Total Current Liabilities4.76
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Due to Affiliate, Noncurrent0.00
Accrued Offering Costs0.00
Total Liabilities4.76
Stockholders' Equity
Common Stock Value One0.00
Retained Earnings / Accumulated Deficit-3.01
Other Equity0.00
Common Stockholder's Equity-121.93
Non-controlling interests & other118.92
Total Stockholder's Equity-3.01
Liabilities & Stockholder's Equity120.67
4 historic quarters locked

Sign in to unlock the full Lava Medtech Acquisition balance sheet history.

About Lava Medtech Acquisition Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-23-024205

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.